PharmaCyte Biotech (NASDAQ:PMCB – Get Free Report) issued its earnings results on Monday. The company reported ($0.10) earnings per share for the quarter, Zacks reports.
PharmaCyte Biotech Price Performance
Shares of PMCB remained flat at $1.58 on Monday. The company had a trading volume of 1,528 shares, compared to its average volume of 24,252. PharmaCyte Biotech has a 1-year low of $1.39 and a 1-year high of $2.58. The stock has a market cap of $10.85 million, a price-to-earnings ratio of 2.98 and a beta of -0.25. The company’s fifty day moving average is $1.65 and its 200-day moving average is $1.70.
About PharmaCyte Biotech
See Also
- Five stocks we like better than PharmaCyte Biotech
- What is the Dow Jones Industrial Average (DJIA)?
- Can TikTok Stock Picks Really Make You Rich?
- How to Invest in the Best Canadian Stocks
- The “Quality” Rotation: Back to Basics Investing
- What Are Trending Stocks? Trending Stocks Explained
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for PharmaCyte Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaCyte Biotech and related companies with MarketBeat.com's FREE daily email newsletter.